Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-01-21, Stock:JNJ, The news for the past five days is as follows:
2020-01-13: NEWS1: Why Johnson & Johnson (JNJ) Could Beat Earnings Estimates Again.NEWS2: New Study Could Clear Johnson & Johnson on Talc, but Is It a Buy Signal?.NEWS3: Glaxo Files Marketing Application for Fostemsavir in Europe.NEWS4: The Zacks Analyst Blog Highlights: JPMorgan Chase, Johnson & Johnson, American Express Company, NIKE and Apple.NEWS5: Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?.
2020-01-14: NEWS1: Johnson & Johnson -- Moody's announces completion of a periodic review of ratings of Johnson & Johnson.NEWS2: Healthpeak (PEAK) Leases Phase II at The Shore at Sierra Point.
2020-01-15: NEWS1: Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know.NEWS2: Johnson & Johnson (JNJ) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release.NEWS3: 3 Large-Cap Dividend Stocks to Buy Now for Your 2020 Portfolio.
2020-01-16: NEWS1: Yacktman Fund's Biggest Buys of 4th-Quarter 2019.NEWS2: Q4 Earnings Scorecard & Today's Top Stock Research Reports.NEWS3: Will Dow ETFs Continue to Surge as Q4 Earnings Unfold?.NEWS4: T. Rowe Price Equity Income Fund Invests in Utility Company CenterPoint Energy.NEWS5: 4 Blue-Chip Stocks to Win Big on Phase-One Trade Deal.NEWS6: J&J Seeks Label Expansion for Spravato Nasal Spray in EU.NEWS7: 3 Medical Product Stocks Set to Beat This Earnings Season.NEWS8: 4 Must-Buy Dow Stocks Ahead of Earnings Reports This Month.NEWS9: Healthcare AI firm hiring, considering M&A after $150M raise.
2020-01-17: NEWS1: Yacktman Focused Fund's Top 5 Sells in the 4th Quarter.NEWS2: Judge Cuts $8 Billion J&J Jury Award to $6 Million.NEWS3: Q4 Earnings Season Showing Revenue Momentum.NEWS4: Judge slashes $8 bln Risperdal award against Johnson & Johnson to $6.8 mln.NEWS5: The Zacks Analyst Blog Highlights: AAPL, JNJ, PG and AXP.NEWS6: The Zacks Analyst Blog Highlights: JPM, JNJ, CVX and PG.NEWS7: Is Johnson & Johnson (JNJ) A Good Pick for Value Investors?.NEWS8: Will J&J (JNJ) Roll Out Pharma Q4 Earnings With a Beat?.NEWS9: Pharma Stock Roundup: LLY Dermira Buyout Offer, Pipeline & Regulatory Updates.

Answer: Rise